GlassScriptPhysician profile
Eddy M Feliz
NPI 1568639219
$2,635.12
in general payments reported to CMS, 2019-2025
22 companies · $21.46 in 2025
The $21.46 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,376 · 2020: $333 · 2021: $12.15 · 2022: $624 · 2024: $268 · 2025: $21.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $289.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electronic Waveform Lab, INC. | $436.24 | 2019-2022 | |
| Spinal Simplicity, LLC | $365.87 | 2022 | |
| Scilex Pharmaceuticals INC. | $362.50 | 2019-2020 | |
| Stimwave Technologies Incorporated | $180.43 | 2019 | |
| Boston Scientific Corporation | $180.08 | 2019-2024 | Spectra Wavewriter |
| Painteq LLC | $167.68 | 2024 | Painteq |
| Medtronic USA, INC. | $153.14 | 2019-2020 | |
| Zyla Life Sciences, INC. | $119.21 | 2019 | |
| Si-Bone, INC. | $111.20 | 2019 | |
| Pfizer INC. | $94.02 | 2019-2024 | |
| Medtronic, INC. | $85.41 | 2022-2025 | Inceptiv |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $75.65 | 2019-2020 | |
| Tersera Therapeutics LLC | $56.02 | 2019 | |
| Biodelivery Sciences International, INC. | $46.71 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.16 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $30.41 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $27.62 | 2019-2020 | |
| Redhill Biopharma INC. | $26.08 | 2020 | |
| Amgen INC. | $23.17 | 2019 | |
| Antares Pharma, INC. | $23.09 | 2022 | |
| Lilly USA, LLC | $14.28 | 2019 | |
| Abbvie INC. | $12.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eddy Feliz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.